Dipraglurant
id:
dipraglurant-318-17145239
title:
Dipraglurant
text:
Dipraglurant (INN) is a negative allosteric modulator of the mGlu5 receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). As of 2014, it is in phase II clinical trials for this indication. Addex Therapeutics is also investigating an extended-release formulation of dipraglurant for the treatment of non-parkinsonian dystonia.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Dipraglurant
date created:
date modified:
2024-02-03T00:54:20Z
main entity:
{"identifier":"Q19596938","url":"https://www.wikidata.org/entity/Q19596938"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/fa/Dipraglurant.svg","width":1490,"height":900}
fields total:
13
integrity:
15